0001077183-19-000058.txt : 20190506
0001077183-19-000058.hdr.sgml : 20190506
20190506173154
ACCESSION NUMBER: 0001077183-19-000058
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190502
FILED AS OF DATE: 20190506
DATE AS OF CHANGE: 20190506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHOVLIN ROBERT J.
CENTRAL INDEX KEY: 0001621453
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 19800508
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
BUSINESS PHONE: 9419231949
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
4
1
wf-form4_155717829283180.xml
FORM 4
X0306
4
2019-05-02
0
0001077183
NEOGENOMICS INC
NEO
0001621453
SHOVLIN ROBERT J.
12701 COMMONWEALTH DRIVE SUITE 9
FORT MYERS
FL
33913
0
1
0
0
President, Clinical Services
Common Stock
2019-05-02
4
M
0
66666
7.15
A
214987
D
Common Stock
2019-05-02
4
M
0
66667
7.52
A
281654
D
Common Stock
2019-05-02
4
S
0
52680
22.14
D
228974
D
Common Stock
2019-05-02
4
S
0
66667
22.14
D
162307
D
Stock Option (Right to Buy)
7.15
2019-05-02
4
M
0
66666
0
D
2017-04-20
2021-04-20
Common Stock
66666.0
0
D
Stock Option (Right to Buy)
8.03
2019-02-26
2023-02-26
Common Stock
288500.0
288500
D
Stock Option (Right to Buy)
7.52
2019-05-02
4
M
0
66667
0
D
2018-04-28
2022-04-28
Common Stock
66667.0
66667
D
Stock Option (Right to Buy)
19.6
2020-03-01
2024-03-01
Common Stock
66897.0
66897
D
On April 20, 2016, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On March 1, 2019, Mr. Shovlin was granted an option to purchase 66,897 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.
/s/ Robert J. Shovlin
2019-05-06